Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of oral glibenclamide in patients with traumatic brain injury
IRCT2014121720353N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of glibenclamide in traumatic brain injury (TBI) and cerebral contusion, sponsored by Shiraz University of Medical Sciences. Started Apr 2015; status: completed.
02
Drugs
glibenclamide
03
Conditions
traumatic brain injury (TBI)cerebral contusion
Beyond the preview
Go deeper on IRCT2014121720353N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014121720353N1.